Fig. 2From: Long-term outcomes of patients with end-stage kidney disease due to membranoproliferative glomerulonephritis: an ANZDATA registry studyKaplan Meier analysis of dialysis patient survival in individuals with MPGN vs. matched controls with all other GN who started dialysis in Australia and New Zealand between 1996 and 2016Back to article page